{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:41:40Z","timestamp":1790919700302,"version":"4.1.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.plipres.2009.10.004","type":"journal-article","created":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T10:50:06Z","timestamp":1257591006000},"page":"159-170","source":"Crossref","is-referenced-by-count":78,"title":["Dietary fats, cerebrovasculature integrity and Alzheimer\u2019s disease risk"],"prefix":"10.1016","volume":"49","author":[{"given":"R.","family":"Takechi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.S.","family":"Pallebage-Gamarallage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.L.","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2009.10.004_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0006-8993(88)90673-7","article-title":"Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer\u2019s disease and normal aging","volume":"474","author":"Joachim","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.410240110","article-title":"Clinically diagnosed Alzheimer\u2019s disease: autopsy results in 150 cases","volume":"24","author":"Joachim","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.plipres.2009.10.004_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.plipres.2009.10.004_bib5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.biocel.2008.12.015","article-title":"Reassessing the amyloid cascade hypothesis of Alzheimer\u2019s disease","volume":"41","author":"Pimplikar","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbagen.2009.07.016","article-title":"The unsolved relationship of brain aging and late-onset Alzheimer disease","volume":"1790","author":"Kern","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2009.10.004_bib7","doi-asserted-by":"crossref","first-page":"21153","DOI":"10.1074\/jbc.273.33.21153","article-title":"Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer\u2019s disease mutation to increase secretion of Abeta42","volume":"273","author":"Tomita","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.18388\/abp.2005_3454","article-title":"Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer\u2019s disease","volume":"52","author":"Kirkitadze","year":"2005","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.plipres.2009.10.004_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.plipres.2009.10.004_bib11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.1_Suppl_1.S2","article-title":"Alzheimer\u2019s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities","volume":"51","author":"Cummings","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib12","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1523\/JNEUROSCI.3697-05.2005","article-title":"IgG-assisted age-dependent clearance of Alzheimer\u2019s amyloid beta peptide by the blood\u2013brain barrier neonatal Fc receptor","volume":"25","author":"Deane","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.plipres.2009.10.004_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood\u2013brain barrier: implication for therapies in Alzheimer\u2019s disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.plipres.2009.10.004_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/153537020523001011","article-title":"The choroid plexus removes beta-amyloid from brain cerebrospinal fluid","volume":"230","author":"Crossgrove","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.plipres.2009.10.004_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jnen\/59.7.561","article-title":"Choroid plexus in the central nervous system: biology and physiopathology","volume":"59","author":"Strazielle","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.plipres.2009.10.004_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","article-title":"Blood\u2013brain barrier transport of circulating Alzheimer\u2019s amyloid beta","volume":"197","author":"Zlokovic","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2009.10.004_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)12462-9","article-title":"Blood\u2013brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer\u2019s amyloid beta in guinea pigs","volume":"206","author":"Martel","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.plipres.2009.10.004_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0024-3205(94)00331-9","article-title":"Passage of human amyloid beta-protein 1\u201340 across the murine blood\u2013brain barrier","volume":"55","author":"Maness","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.plipres.2009.10.004_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0074-7742(09)00403-6","article-title":"Cerebrovascular and cardiovascular pathology in Alzheimer\u2019s disease","volume":"84","author":"de la Torre","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.plipres.2009.10.004_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.wnl.0000341271.90478.8e","article-title":"Vascular risk factors and dementia: how to move forward?","volume":"72","author":"Viswanathan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/VHRM.S1839","article-title":"Vascular risk factors, cognitive decline, and dementia","volume":"4","author":"Duron","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.plipres.2009.10.004_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1076-7460.2007.06696.x","article-title":"Cardiovascular risk factors for Alzheimer\u2019s disease","volume":"16","author":"Rosendorff","year":"2007","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.plipres.2009.10.004_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1179\/016164106X130407","article-title":"Cardiovascular disease and risk of Alzheimer\u2019s disease","volume":"28","author":"Rosano","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(96)05832-7","article-title":"Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study","volume":"124","author":"Meyer","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2009.10.004_bib27","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.CIR.88.6.2762","article-title":"Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events","volume":"88","author":"Phillips","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2009.10.004_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00041433-200210000-00001","article-title":"Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis","volume":"13","author":"Proctor","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2009.10.004_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.5858\/133.8.1309","article-title":"Arteriosclerosis: rethinking the current classification","volume":"133","author":"Fishbein","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib30","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jama.292.12.1454","article-title":"Physical activity, including walking, and cognitive function in older women","volume":"292","author":"Weuve","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2009.10.004_bib31","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.292.12.1447","article-title":"Walking and dementia in physically capable elderly men","volume":"292","author":"Abbott","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2009.10.004_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-144-2-200601170-00004","article-title":"Exercise is associated with reduced risk for incident dementia among persons 65years of age and older","volume":"144","author":"Larson","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/aje\/kwi092","article-title":"Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study","volume":"161","author":"Podewils","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.plipres.2009.10.004_bib34","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1212\/01.WNL.0000147474.29994.35","article-title":"Physical activity in relation to cognitive decline in elderly men: the FINE study","volume":"63","author":"van Gelder","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-2008-1038432","article-title":"Exercise training is beneficial for Alzheimer\u2019s patients","volume":"29","author":"Santana-Sosa","year":"2008","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib36","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1007\/BF02982595","article-title":"Alzheimer\u2019s disease \u2013 the ways of prevention","volume":"12","author":"Kivipelto","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.plipres.2009.10.004_bib37","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1471-4159.2008.05454.x","article-title":"Metabolic syndrome and the role of dietary lifestyles in Alzheimer\u2019s disease","volume":"106","author":"Pasinetti","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Demen"},{"key":"10.1016\/j.plipres.2009.10.004_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s003910170074","article-title":"Dementia in advanced age: estimating incidence and health care costs","volume":"34","author":"Bickel","year":"2001","journal-title":"Z Gerontol Geriatr"},{"key":"10.1016\/j.plipres.2009.10.004_bib40","doi-asserted-by":"crossref","unstructured":"Guest Editors 2008 Alzheimer\u2019s disease facts and figures. Alzheimers Demen 2008;4:110\u2013133.","DOI":"10.1016\/j.jalz.2008.02.005"},{"key":"10.1016\/j.plipres.2009.10.004_bib41","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","article-title":"Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: the CERAD experience, Part XV","volume":"46","author":"Ellis","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1997.tb48468.x","article-title":"Amyloid angiopathy and blood\u2013brain barrier changes in Alzheimer\u2019s disease","volume":"826","author":"Wisniewski","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.plipres.2009.10.004_bib43","first-page":"226","article-title":"The blood\u2013brain barrier and cerebral microcirculation in Alzheimer disease","volume":"4","author":"Kalaria","year":"1992","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1016\/j.plipres.2009.10.004_bib44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/00001756-199705260-00033","article-title":"Perivascular astrocytes within Alzheimer\u2019s disease plaques","volume":"8","author":"Cullen","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.plipres.2009.10.004_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","article-title":"Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease","volume":"24","author":"Itagaki","year":"1989","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.plipres.2009.10.004_bib46","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1212\/01.wnl.0000278116.37320.52","article-title":"Dietary patterns and risk of dementia: the three-city cohort study","volume":"69","author":"Barberger-Gateau","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib47","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jada.2009.06.367","article-title":"Diet based on the Japanese food guide spinning top and subsequent mortality among men and women in a general Japanese population","volume":"109","author":"Oba","year":"2009","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.plipres.2009.10.004_bib48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2009.10.004_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1007529206050","article-title":"Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the seven countries study. The seven countries study research group","volume":"15","author":"Menotti","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.plipres.2009.10.004_bib50","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(02)11472-3","article-title":"Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean diet heart study): a randomised single-blind trial","volume":"360","author":"Singh","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2009.10.004_bib51","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ajcn\/82.5.964","article-title":"The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet","volume":"82","author":"Vincent-Baudry","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.plipres.2009.10.004_bib52","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0735-1097(96)00280-X","article-title":"Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments","volume":"28","author":"De Lorgeril","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2009.10.004_bib53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2009.10.004_bib54","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/01.WNL.0000038345.77753.46","article-title":"Diet and risk of dementia: does fat matter? The Rotterdam study","volume":"59","author":"Engelhart","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/archneur.60.2.194","article-title":"Dietary fats and the risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib56","first-page":"202","article-title":"Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies","volume":"4","author":"Kalmijn","year":"2000","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.plipres.2009.10.004_bib57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(04)00878-6","article-title":"Dietary factors and Alzheimer\u2019s disease","volume":"3","author":"Luchsinger","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.exger.2005.01.001","article-title":"Dietary fatty acids intake: possible role in cognitive decline and dementia","volume":"40","author":"Solfrizzi","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.plipres.2009.10.004_bib59","article-title":"Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms","author":"Solfrizzi","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.plipres.2009.10.004_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000093478","article-title":"Fat intake at midlife and risk of dementia and Alzheimer\u2019s disease: a population-based study","volume":"22","author":"Laitinen","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.plipres.2009.10.004_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nbd.2006.04.013","article-title":"Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP\/PS1 transgenic mice","volume":"23","author":"Oksman","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00001756-200203250-00019","article-title":"Diet-induced hypercholesterolemia enhances brain a beta accumulation in transgenic mice","volume":"13","author":"Shie","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.plipres.2009.10.004_bib65","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham heart study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nbd.2008.12.002","article-title":"DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe\/PS1dE9 mice","volume":"33","author":"Hooijmans","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib67","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","article-title":"A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model","volume":"25","author":"Lim","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.plipres.2009.10.004_bib68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2007.06.007","article-title":"Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP\/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched typical western diet (TWD)","volume":"28","author":"Hooijmans","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/026010600601800307","article-title":"Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Cole","year":"2006","journal-title":"Nutr Health"},{"key":"10.1016\/j.plipres.2009.10.004_bib70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archneurol.2008.536","article-title":"Mediterranean diet and mild cognitive impairment","volume":"66","author":"Scarmeas","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2004.09.007","article-title":"Lipids, diet and Alzheimer disease: an extended summary","volume":"226","author":"Petot","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.plipres.2009.10.004_bib72","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2008.05.061","article-title":"Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition","volume":"155","author":"Wu","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.plipres.2009.10.004_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.plipres.2009.04.001","article-title":"Fish, docosahexaenoic acid and Alzheimer\u2019s disease","volume":"48","author":"Cunnane","year":"2009","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib74","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2007.08.018","article-title":"A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer\u2019s transgenic mice","volume":"149","author":"Arendash","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.plipres.2009.10.004_bib75","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.2008.05274.x","article-title":"Docosahexaenoic acid synthesis from n-3 fatty acid precursors in rat hippocampal neurons","volume":"105","author":"Kaduce","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000111648","article-title":"Postnatal dietary fat influences mRNAS involved in myelination","volume":"14","author":"DeWille","year":"1992","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.plipres.2009.10.004_bib77","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1073\/pnas.0337683100","article-title":"Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus","volume":"100","author":"Puskas","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plipres.2009.10.004_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0952-3278(03)00107-8","article-title":"Potential role of dietary omega-3 essential fatty acids on some oxidant\/antioxidant parameters in rats\u2019 corpus striatum","volume":"69","author":"Sarsilmaz","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.plipres.2009.10.004_bib79","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators","volume":"3","author":"Serhan","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.plipres.2009.10.004_bib80","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1471-4159.2002.00905.x","article-title":"Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer\u2019s disease model rats","volume":"81","author":"Hashimoto","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib81","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1996.0940","article-title":"Biochemical characterization of Alzheimer\u2019s soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins","volume":"223","author":"Koudinov","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2009.10.004_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1258\/0004563053026826","article-title":"The immunodetection of lipoprotein-bound amyloid-beta is attenuated because of the presence of lipids","volume":"42","author":"James","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-5793(97)01484-1","article-title":"Amyloid beta-protein (A beta) associated with lipid molecules: immunoreactivity distinct from that of soluble A beta","volume":"420","author":"Yanagisawa","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2009.10.004_bib84","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib85","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1258\/acb.2008.007214","article-title":"Plasma lipoprotein beta-amyloid in subjects with Alzheimer\u2019s disease or mild cognitive impairment","volume":"45","author":"Mamo","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib86","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/cbir.1996.0126","article-title":"Alzheimer\u2019s soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein","volume":"21","author":"Koudinov","year":"1997","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.plipres.2009.10.004_bib87","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jnutbio.2006.07.003","article-title":"Beta-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding","volume":"18","author":"Galloway","year":"2007","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-511X-7-15","article-title":"Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance","volume":"7","author":"Galloway","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib89","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S0007114508012269","article-title":"The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance","volume":"101","author":"Pallebage-Gamarallage","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/j.plipres.2009.10.004_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosissup.2008.05.010","article-title":"Chylomicron amyloid-beta in the aetiology of Alzheimer\u2019s disease","volume":"9","author":"Takechi","year":"2008","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.plipres.2009.10.004_bib91","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00418-008-0404-0","article-title":"Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus","volume":"129","author":"Takechi","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib92","first-page":"339","article-title":"Relationship between lipid metabolism and amyloid precursor protein and apolipoprotein E","volume":"2","author":"Boyt","year":"1999","journal-title":"Alzheimer\u2019s Rep"},{"key":"10.1016\/j.plipres.2009.10.004_bib93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-2003-5302","article-title":"The incorporation and metabolism of amyloid-beta into chylomicron-like lipid emulsions","volume":"5","author":"James","year":"2003","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib94","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1194\/jlr.M500382-JLR200","article-title":"Saturated fat-induced changes in Sf 60\u2013400 particle composition reduces uptake of LDL by HepG2 cells","volume":"47","author":"Jackson","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(01)00622-0","article-title":"Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia","volume":"161","author":"Roberts","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2009.10.004_bib96","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0952-3278(97)90420-8","article-title":"Saturated fatty acids and LDL receptor modulation in humans and monkeys","volume":"57","author":"Hayes","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.plipres.2009.10.004_bib97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ecl.2008.11.005","article-title":"Hypertriglyceridemia: impact and treatment","volume":"38","author":"Goldberg","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.plipres.2009.10.004_bib98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0026-0495(99)90076-8","article-title":"Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease","volume":"48","author":"Karpe","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2009.10.004_bib99","first-page":"239","article-title":"Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins","volume":"7","author":"Proctor","year":"1996","journal-title":"Coron Artery Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2009.10.004_bib100","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0021-9150(98)00220-2","article-title":"Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma","volume":"141","author":"Mamo","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2009.10.004_bib101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nbd.2006.06.007","article-title":"Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer\u2019s disease mouse models with abundant A beta in plasma","volume":"24","author":"Burgess","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib102","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0304-3940(92)90531-B","article-title":"Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer\u2019s disease","volume":"134","author":"Namba","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.plipres.2009.10.004_bib103","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"ApoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2009.10.004_bib104","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0508693102","article-title":"Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target","volume":"102","author":"Ye","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plipres.2009.10.004_bib105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00418-009-0567-3","article-title":"Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP\/PS1 transgenic mice","volume":"131","author":"Takechi","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib106","unstructured":"Takechi R, Galloway S, Pallebage-Gamarallage M, Wellington C, Johnsen R, Dahliwal S, et al. Differential effects of dietary fatty acids on the cerebral distribution of plasma derived apo B lipoproteins with amyloid-beta. Br J Nutr 2009;28:1\u201311. PMID: 19860996. [Epub ahead of print]."},{"key":"10.1016\/j.plipres.2009.10.004_bib107","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/00001756-199704140-00014","article-title":"Cerebrovascular endothelial dysfunction mediated by beta-amyloid","volume":"8","author":"Thomas","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.plipres.2009.10.004_bib108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2004.01.009","article-title":"APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease","volume":"16","author":"George","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.plipres.2009.10.004_bib109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jneumeth.2004.04.026","article-title":"Method for measurement of the blood\u2013brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer\u2019s Tg2576 mice","volume":"138","author":"LaRue","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.plipres.2009.10.004_bib110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","article-title":"Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker","volume":"68","author":"Bateman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2009.10.004_bib111","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2337\/diabetes.44.8.863","article-title":"Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications","volume":"44","author":"Unger","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.plipres.2009.10.004_bib112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MCO.0b013e328321e423","article-title":"Fatty acids and beta-cell toxicity","volume":"12","author":"Morgan","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.plipres.2009.10.004_bib113","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1756-0500-1-20","article-title":"Brain region-specificity of palmitic acid-induced abnormalities associated with Alzheimer\u2019s disease","volume":"1","author":"Patil","year":"2008","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.plipres.2009.10.004_bib114","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1042\/BST0360959","article-title":"Differential regulation of the ER stress response by long-chain fatty acids in the pancreatic beta-cell","volume":"36","author":"Diakogiannaki","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.plipres.2009.10.004_bib115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.2008.05798.x","article-title":"Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice","volume":"108","author":"Studzinski","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib116","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.2006.02474.x","article-title":"The endocrine function of adipose tissue: an update","volume":"64","author":"Ronti","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.plipres.2009.10.004_bib117","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.biochi.2009.03.004","article-title":"The essential role of lipids in Alzheimer\u2019s disease","volume":"91","author":"Florent-Bechard","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.plipres.2009.10.004_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbamem.2008.10.011","article-title":"Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes","volume":"1788","author":"Wassall","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2009.10.004_bib119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0009-3084(04)00140-9","article-title":"Order from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formation","volume":"132","author":"Wassall","year":"2004","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.plipres.2009.10.004_bib120","doi-asserted-by":"crossref","first-page":"39368","DOI":"10.1074\/jbc.M202376200","article-title":"The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts","volume":"277","author":"Diaz","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib121","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-4159.2006.04079.x","article-title":"Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets","volume":"99","author":"Ghribi","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib122","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00001756-199906030-00014","article-title":"The role of cholesterol in the biosynthesis of beta-amyloid","volume":"10","author":"Frears","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.plipres.2009.10.004_bib123","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1083\/jcb.200404149","article-title":"Neuronal membrane cholesterol loss enhances amyloid peptide generation","volume":"167","author":"Abad-Rodriguez","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib124","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1471-4159.2003.01552.x","article-title":"Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes","volume":"84","author":"Subasinghe","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ncb1035","article-title":"The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages","volume":"5","author":"Feng","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib126","doi-asserted-by":"crossref","first-page":"42468","DOI":"10.1074\/jbc.M101419200","article-title":"Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway","volume":"276","author":"Yao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib127","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0021-9150(95)05594-M","article-title":"Toxicity of oxysterols to human monocyte-macrophages","volume":"118","author":"Clare","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2009.10.004_bib128","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ajcn\/32.5.1033","article-title":"Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis","volume":"32","author":"Peng","year":"1979","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.plipres.2009.10.004_bib129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0014-5793(02)02646-7","article-title":"An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis","volume":"518","author":"Stanyer","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2009.10.004_bib130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","article-title":"Apolipoprotein E and Alzheimer\u2019s disease","volume":"19","author":"Strittmatter","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.plipres.2009.10.004_bib131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","article-title":"Amyloid-beta, and blood\u2013brain barrier permeability in Alzheimer disease","volume":"67","author":"Donahue","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib132","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.plipres.2009.10.004_bib133","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1471-4159.2004.02581.x","article-title":"Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein","volume":"90","author":"Irizarry","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib134","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H","article-title":"Association of human, rat, and rabbit apolipoprotein E with beta-amyloid","volume":"49","author":"LaDu","year":"1997","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041433-199906000-00003","article-title":"Apolipoprotein E: from atherosclerosis to Alzheimer\u2019s disease and beyond","volume":"10","author":"Mahley","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2009.10.004_bib136","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer\u2019s disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2009.10.004_bib137","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plipres.2009.10.004_bib138","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/JMN:23:3:151","article-title":"Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer\u2019s disease","volume":"23","author":"Refolo","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.plipres.2009.10.004_bib139","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mnfr.200700322","article-title":"Impact of apoE genotype on oxidative stress, inflammation and disease risk","volume":"52","author":"Jofre-Monseny","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.plipres.2009.10.004_bib141","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.plipres.2009.10.004_bib142","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-2275(20)41527-5","article-title":"Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100","volume":"33","author":"Campos","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib143","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00109-002-0351-5","article-title":"Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo","volume":"80","author":"Heeren","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib144","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-2275(20)42004-8","article-title":"Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP)","volume":"37","author":"Krapp","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0005-2760(91)90277-O","article-title":"Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits","volume":"1081","author":"Mamo","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2009.10.004_bib146","doi-asserted-by":"crossref","first-page":"40723","DOI":"10.1074\/jbc.M304814200","article-title":"Effects of polymorphism on the lipid interaction of human apolipoprotein E","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib147","doi-asserted-by":"crossref","first-page":"39138","DOI":"10.1074\/jbc.M104746200","article-title":"New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E","volume":"276","author":"Libeu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib148","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-2275(20)33303-4","article-title":"Apolipoprotein E2 (Arg136\u2192Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia","volume":"39","author":"Marz","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib149","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-2275(20)39754-6","article-title":"Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3\u2019 (Arg136\u2192His): association with mild dyslipidemia and double pre-beta very low density lipoproteins","volume":"36","author":"Minnich","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib150","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0021-9258(18)46040-1","article-title":"The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia","volume":"267","author":"Horie","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib151","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1016\/S0021-9258(17)36849-7","article-title":"Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia","volume":"269","author":"Ji","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib152","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-2275(20)39885-0","article-title":"Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia","volume":"36","author":"Mann","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib153","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0014-5793(99)01285-5","article-title":"Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix","volume":"459","author":"Shuvaev","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2009.10.004_bib154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20010057","article-title":"Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins","volume":"101","author":"Elsegood","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.plipres.2009.10.004_bib155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0003-9861(85)90704-0","article-title":"The secretion of apolipoprotein E by human monocyte-derived macrophages","volume":"239","author":"Kayden","year":"1985","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.plipres.2009.10.004_bib156","first-page":"461","article-title":"Lipoprotein receptors","volume":"40","author":"Lestavel","year":"1994","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.plipres.2009.10.004_bib157","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cardiores.2005.08.013","article-title":"Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model","volume":"69","author":"Hinagata","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib158","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1074\/jbc.M610712200","article-title":"Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner","volume":"282","author":"Altenburg","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib159","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS19990182","article-title":"Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis","volume":"98","author":"Yu","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.plipres.2009.10.004_bib160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0301-0082(02)00127-2","article-title":"An inflammatory review of Parkinson\u2019s disease","volume":"68","author":"Orr","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.plipres.2009.10.004_bib161","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-5793(95)00764-Z","article-title":"Nitric oxide and oxygen radicals: a question of balance","volume":"369","author":"Darley-Usmar","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2009.10.004_bib162","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.plipres.2009.10.004_bib163","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0197-4580(96)00103-0","article-title":"Neuroglial-mediated immunoinflammatory responses in Alzheimer\u2019s disease: complement activation and therapeutic approaches","volume":"17","author":"Chen","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.plipres.2009.10.004_bib164","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0891-5849(98)00293-7","article-title":"Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development","volume":"26","author":"Floyd","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","article-title":"The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor","volume":"46","author":"Ruiz","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib166","series-title":"Lehninger principles of biochemistry","author":"Nelson","year":"2005"},{"key":"10.1016\/j.plipres.2009.10.004_bib167","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1474-4422(03)00484-8","article-title":"Heparan sulphate proteoglycans in Alzheimer\u2019s disease and amyloid-related disorders","volume":"2","author":"van Horssen","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.plipres.2009.10.004_bib168","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.1074\/jbc.M204053200","article-title":"Identification of the proteoglycan binding site in apolipoprotein B48","volume":"277","author":"Flood","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib169","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.272.27.17005","article-title":"\u2217\u2217\u2217Abeta(1\u201340) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer\u2019s disease","volume":"272","author":"Bame","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2009.10.004_bib170","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Skalen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2009.10.004_bib171","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00041433-200410000-00003","article-title":"Mechanism of lipoprotein retention by the extracellular matrix","volume":"15","author":"Gustafsson","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2009.10.004_bib172","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1152\/physrev.2000.80.4.1267","article-title":"Proteoglycans in the developing brain: new conceptual insights for old proteins","volume":"80","author":"Bandtlow","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.plipres.2009.10.004_bib173","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.67.1.609","article-title":"Matrix proteoglycans: from molecular design to cellular function","volume":"67","author":"Iozzo","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib174","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.1996.67030889.x","article-title":"Role of proteoglycans in neural development, regeneration, and the aging brain","volume":"67","author":"Small","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2796.2005.01556.x","article-title":"Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis","volume":"258","author":"Olofsson","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib176","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/hq0302.105378","article-title":"Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis","volume":"22","author":"Kunjathoor","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib177","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.98.6.519","article-title":"Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins","volume":"98","author":"O\u2019Brien","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2009.10.004_bib178","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.ATV.21.1.129","article-title":"Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE","volume":"21","author":"Olin","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib179","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2004.07.007","article-title":"Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis","volume":"177","author":"O\u2019Brien","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2009.10.004_bib180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9150(97)00158-5","article-title":"Elevated expression of proteoglycans in proliferating vascular smooth muscle cells","volume":"135","author":"Tao","year":"1997","journal-title":"Atherosclerosis"},{"issue":"Pt 3","key":"10.1016\/j.plipres.2009.10.004_bib181","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1242\/jcs.103.3.857","article-title":"Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy","volume":"103","author":"Manders","year":"1992","journal-title":"J Cell Sci"},{"key":"10.1016\/j.plipres.2009.10.004_bib182","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1046\/j.1471-4159.1997.69062452.x","article-title":"Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer\u2019s disease, accelerates A beta fibril formation, and maintains A beta fibril stability","volume":"69","author":"Castillo","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2009.10.004_bib183","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/abbi.1995.1345","article-title":"Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer\u2019s disease","volume":"320","author":"Snow","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.plipres.2009.10.004_bib184","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1079\/PNS19970050","article-title":"Apolipoprotein B-48 as a marker for chylomicrons and their remnants: studies in the postprandial state","volume":"56","author":"Isherwood","year":"1997","journal-title":"Proc Nutr Soc"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2009.10.004_bib185","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0021-9150(98)00212-3","article-title":"Chylomicron synthesis by intestinal cells in vitro and in vivo","volume":"141","author":"van Greevenbroek","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2009.10.004_bib186","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0404.1999.tb00724.x","article-title":"Increased apolipoprotein B serum concentration in Alzheimer\u2019s disease","volume":"100","author":"Caramelli","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.plipres.2009.10.004_bib187","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1515\/CCLM.2003.120","article-title":"Identification of lipoproteins of intestinal origin in human atherosclerotic plaque","volume":"41","author":"Pal","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.plipres.2009.10.004_bib188","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.0000084638.14534.0A","article-title":"Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits","volume":"23","author":"Proctor","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2009.10.004_bib189","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/pr060571b","article-title":"Overexpression of biglycan in the heart of transgenic mice. An antibody microarray study","volume":"6","author":"Bereczki","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.plipres.2009.10.004_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam study","volume":"80","author":"Haag","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.plipres.2009.10.004_bib191","doi-asserted-by":"crossref","unstructured":"McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev 2009;15: CD003160. Review. PMID: 19370582.","DOI":"10.1002\/14651858.CD003160.pub2"},{"key":"10.1016\/j.plipres.2009.10.004_bib192","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JGP.0b013e318181276a","article-title":"Effects of cardiovascular medications on rate of functional decline in Alzheimer disease","volume":"16","author":"Rosenberg","year":"2008","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782709000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782709000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T14:17:17Z","timestamp":1710685037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782709000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":192,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0163782709000563"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2009.10.004","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}